DOXOCRED-A

Doxocred-A: Doxofylline 400mg & Ambroxol 60mg Tablets – Advanced Respiratory Support

Doxocred-A is a specialized dual-action pharmaceutical formulation designed to provide comprehensive support for respiratory wellness. By combining Doxofylline 400mg and Ambroxol Hydrochloride 60mg, this medication offers a synergistic approach to managing various chronic and acute respiratory conditions. This combination is widely recognized for its ability to improve breathing efficiency and facilitate clearer airways, significantly enhancing the daily quality of life for individuals with lung-related concerns.

Understanding the Formulation: How Doxocred-A Works

The effectiveness of Doxocred-A lies in its unique two-pronged mechanism that addresses both the tightness of the airways and the presence of excessive mucus.

1. Doxofylline (400mg): The Modern Bronchodilator

Doxofylline is a next-generation methylxanthine derivative used to treat chronic obstructive pulmonary disease (COPD) and asthma.

• Airway Relaxation: It works by relaxing the smooth muscles in the bronchial tubes, which are the main passages to the lungs.
• Ease of Breathing: Widening these passages allows for a smoother, more effortless intake of oxygen and expulsion of carbon dioxide.
• Improved Efficiency: Unlike older bronchodilators, Doxofylline is known for its high efficacy in keeping the airways open for extended periods.

2. Ambroxol Hydrochloride (60mg): The Potent Mucolytic

Ambroxol is a trusted mucolytic agent that targets the physical properties of respiratory secretions.

• Thinning Mucus: It acts on the mucus present in the lungs, breaking down its complex structure to make it thinner and less sticky.
• Facilitating Clearance: By reducing the viscosity of phlegm, Ambroxol makes it much easier for the body’s natural “cough reflex” or “ciliary action” to clear the airways.
• Surface Protection: It also stimulates the production of surfactant, a substance that prevents the small air sacs in the lungs from sticking together, further aiding in flexible lung function.

Primary Uses and Therapeutic Benefits

Doxocred-A is highly valued in clinical settings for its ability to provide relief and support in several respiratory scenarios:

1. Management of Chronic Bronchitis
In chronic bronchitis, the bronchial tubes are often inflamed and clogged with thick mucus. Doxocred-A provides dual relief by opening the tubes and thinning the secretions, allowing for clearer breathing throughout the day.

2. Support for Bronchial Asthma

For individuals living with asthma, maintaining open airways is crucial. The Doxofylline component helps prevent the sudden constriction of these passages, while Ambroxol ensures that any associated mucus does not further obstruct breathing.

3. Relief in Chronic Obstructive Pulmonary Disease (COPD)
COPD often involves persistent respiratory symptoms. The combined action of Doxofylline 400mg and Ambroxol 60mg helps manage these symptoms effectively, supporting better exercise tolerance and reducing the frequency of breathlessness.

4. Faster Recovery from Acute Respiratory Infections
During infections where a productive cough is present, Doxocred-A assists the body in clearing the infection-related phlegm more rapidly, helping patients feel lighter and recover their energy faster.

Key Advantages of Doxocred-A Tablets

• Synergistic Action: The combination of a bronchodilator and a mucolytic provides a more complete therapeutic effect than using either medication alone.
• Convenient Dosing: By combining two potent ingredients into a single tablet, Doxocred-A simplifies the treatment regimen for the patient.
• Reliable Formulation: Each tablet is manufactured under strict quality standards to ensure precise delivery of 400mg Doxofylline and 60mg Ambroxol.
• Enhanced Vitality: By significantly reducing the effort required to breathe, this medication helps individuals return to their daily activities with renewed vigor and confidence.

Why Choose Doxocred-A?

Novalab Healthcare is committed to providing advanced therapeutic solutions like Doxocred-A. The medication is presented in a high-quality 10×10 blister pack, which protects the tablets from environmental factors and ensures consistent potency. For healthcare providers and patients looking for a reliable, science-backed approach to respiratory wellness, Doxocred-A stands as a premier choice.

Product Summary

• Product Name: Doxocred-A
• Composition: Doxofylline 400mg + Ambroxol Hydrochloride 60mg
• Category: Tablets / Respiratory Support
• Packaging: 10×10 Blister
• Manufacturer: Novalab Healthcare Pvt. Ltd.

Medical Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional diagnosis. Always seek the advice of your physician or other qualified health provider regarding any medical condition or treatment.